Check out xMAP® Insights Magazine Fall 2023 Edition: Possibilities in Biomarker Discovery
Explore the newest edition of xMAP® Insights magazine to discover valuable insights on leveraging xMAP® multiplexing technology for biomarker discovery. Gain expert advice from our custom assay development group, LuminexPLORE Lab, and access tips to elevate the impact of your upcoming grant application. Plus—you’ll hear from our partners at Bio-Techne, Bio-Rad, MilliporeSigma, and Thermo Fisher Scientific on how they leverage xMAP® Technology to enable research breakthroughs for various disease states.
Exciting times are upon us at Luminex! We’re now shipping new instruments with the latest Software Version 2.0 for the xMAP INTELLIFLEX® System and the xMAP INTELLIFLEX® DR-SE System, which includes numerous updates that enable greater flexibility and ease of use.
Key features include customer experience improvements that streamline tasks and maintain workflow uptime with improved reliability. Plus, it offers two optional software modules to meet electronic records compliance requirements (21 CFR Part 11/EU Annex 11) and integrate with automated equipment.
Check out our brochure to learn more about the xMAP INTELLIFLEX Systems and how this enhanced software can improve your multiplexing process.
xMAP® Technology Enables Early Detection of Alzheimer's Disease Pathology Risk in Pre-Symptomatic Patients
Researchers from Durin Technologies, Rowan University, and Brown University have implemented machine learning using the FLEXMAP 3D® System to analyze blood-based biomarkers when detecting early-stage Alzheimer's disease pathology in pre-symptomatic patients. Learn more about this breakthrough in our latest white paper.
Accurately Measure DNA Abundancies in Human Gut Microbiome Research with Multiplexing Technology
Learn how researchers from Oslo Metropolitan University utilized an xMAP Technology based test for multiplex molecular testing on fecal samples from their home collection kit to generate robust correlations with human microbiome data in our new white paper.
Webinar: Optimizing Cytokine Analysis-Choosing the Right Assay
The growing use of multiplexed cytokine assays in disease research poses design challenges. Nonhuman primates require consideration of demographics and design's effects, while high-quality antibodies are essential for reliable data. xMAP Technology-based performance panels offer advantages in measuring multiple targets without increasing sample volume. Learning objectives cover: assay qualification, variable impacts on cytokine expression, and assay selection criteria.
Inflamed in the Brain: A Protocol for Studying Neuroinflammation in Mouse Brain Tissue
Mice are critical model organisms for the study of neuroinflammation. But tissue quantity is often a limiting factor. In a paper published in Methods, learn how researchers describe a protocol for analyzing 33 cytokines and chemokines using only 50 μl of tissue homogenate.
On-Demand Webinar on New Profiling Strategies for Precursor Lesions of Pancreatic Cancer
Uncover how profiling endocrine and inflammatory biomarkers using MILLIPLEX®® multiplex assays in samples with precursor lesions of pancreatic cancer could help lead to better treatment strategies.
*You will be redirected to a Bitesize Bio registration page for this webinar.
Monitor Immunoassay Method Reproducibility with Belysa® Software
Belysa® software offers a user-friendly way to monitor immunoassay method reproducibility for Luminex instruments. At the individual plate level, between assays, and between lots of assays, there are numerous considerations when evaluating the method that is being applied to a study. Belysa® software allows users to easily monitor their method and ensure it is reproducible over time. Discover more information about this software and schedule a demonstration today.
New Human Hepatotoxicity ProcartaPlex Panels Now Available
Deepen your understanding of the metabolism of your drug candidate by quantifying protein levels of FDA recommended CYP enzymes for ADME/Tox studies with our new Invitrogen™ ProcartaPlex™ Human Liver Toxicity Panels.
Use primary hepatocytes more efficiently to measure gene expression of all relevant ADME and toxicological biomarkers through the analysis of 80 RNA targets in a single well using the InvitrogenTM QuantigeneTM Plex ADME/Tox Panel. This panel includes matching targets to the new Human Liver Toxicity ProcartaPlex Panels and enables you to get a more holistic view of your sample.
These products are for Research Use Only. Not for use in diagnostic procedures. Please contact Luminex at support@luminexcorp.com to obtain the appropriate product information for your country of residence.
-1.png?upscale=true&width=1200&upscale=true&name=Untitled%20design%20(20)-1.png)
